Jeena Sikho Lifecare Insiders Made A Wise Decision By Selling ₹1.9b Worth Of Stock

While it’s been a great week for Jeena Sikho Lifecare Limited (NSE:JSLL) shareholders after stock gained 24%, they should consider it with a grain of salt. Even though stock prices were relatively low, insiders elected to sell ₹1.9b worth of stock in the last year, which could indicate some expected downturn.

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

Jeena Sikho Lifecare Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by the Chairman & MD, Manish Grover, for ₹1.3b worth of shares, at about ₹2,314 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The good news is that this large sale was at well above current price of ₹1,963. So it is hard to draw any strong conclusion from it.

Jeena Sikho Lifecare insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

See our latest analysis for Jeena Sikho Lifecare

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of Jeena Sikho Lifecare

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. Jeena Sikho Lifecare insiders own 64% of the company, currently worth about ₹31b based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Does This Data Suggest About Jeena Sikho Lifecare Insiders?

The fact that there have been no Jeena Sikho Lifecare insider transactions recently certainly doesn't bother us. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Jeena Sikho Lifecare insiders selling. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Our analysis shows 2 warning signs for Jeena Sikho Lifecare (1 doesn't sit too well with us!) and we strongly recommend you look at these before investing.

Of course Jeena Sikho Lifecare may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.